These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9288173)

  • 1. Mapping the peripheral benzodiazepine receptor binding site by conformationally restrained derivatives of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3- isoquinolinecarboxamide (PK11195).
    Cappelli A; Anzini M; Vomero S; De Benedetti PG; Menziani MC; Giorgi G; Manzoni C
    J Med Chem; 1997 Aug; 40(18):2910-21. PubMed ID: 9288173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling.
    Anzini M; Cappelli A; Vomero S; Seeber M; Menziani MC; Langer T; Hagen B; Manzoni C; Bourguignon JJ
    J Med Chem; 2001 Apr; 44(8):1134-50. PubMed ID: 11312914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel irreversible ligands specific for "peripheral" type benzodiazepine receptors: (+/-)-, (+)-, and (-)-1-(2-chlorophenyl)-N-(1-methylpropyl)-N- (2-isothiocyanatoethyl)-3-isoquinolinecarboxamide and 1-(2-isothiocyanatoethyl)-7-chloro-1,3-dihydro-5-(4-chlorophenyl )-2H-1,4-benzodiazepin-2-one.
    Newman AH; Lueddens HW; Skolnick P; Rice KC
    J Med Chem; 1987 Oct; 30(10):1901-5. PubMed ID: 2821259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain.
    Rao VL; Butterworth RF
    Eur J Pharmacol; 1997 Dec; 340(1):89-99. PubMed ID: 9527511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.
    Venneti S; Lopresti BJ; Wang G; Slagel SL; Mason NS; Mathis CA; Fischer ML; Larsen NJ; Mortimer AD; Hastings TG; Smith AD; Zigmond MJ; Suhara T; Higuchi M; Wiley CA
    J Neurochem; 2007 Sep; 102(6):2118-2131. PubMed ID: 17555551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor.
    Yu W; Wang E; Voll RJ; Miller AH; Goodman MM
    Bioorg Med Chem; 2008 Jun; 16(11):6145-55. PubMed ID: 18472268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo receptor labeling of peripheral benzodiazepine receptor by ex vivo binding of [3H]PK11195.
    Funakoshi T; Chaki S; Okuyama S; Okubo T; Nakazato A; Nagamine M; Tomisawa K
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):35-41. PubMed ID: 10850367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral benzodiazepine receptor: characterization in human T-lymphoma Jurkat cells.
    Costa B; Salvetti A; Rossi L; Spinetti F; Lena A; Chelli B; Rechichi M; Da Pozzo E; Gremigni V; Martini C
    Mol Pharmacol; 2006 Jan; 69(1):37-44. PubMed ID: 16189298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligands.
    Campiani G; Nacci V; Fiorini I; De Filippis MP; Garofalo A; Ciani SM; Greco G; Novellino E; Williams DC; Zisterer DM; Woods MJ; Mihai C; Manzoni C; Mennini T
    J Med Chem; 1996 Aug; 39(18):3435-50. PubMed ID: 8784441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem.
    Cappelli A; Giuliani G; Valenti S; Anzini M; Vomero S; Giorgi G; Sogliano C; Maciocco E; Biggio G; Concas A
    Bioorg Med Chem; 2008 Mar; 16(6):3428-37. PubMed ID: 18294852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor.
    Primofiore G; Da Settimo F; Taliani S; Simorini F; Patrizi MP; Novellino E; Greco G; Abignente E; Costa B; Chelli B; Martini C
    J Med Chem; 2004 Mar; 47(7):1852-5. PubMed ID: 15027878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity peripheral benzodiazepine receptor ligand, PK11195, regulates protein phosphorylation in rat brain mitochondria under control of Ca(2+).
    Azarashvili T; Krestinina O; Yurkov I; Evtodienko Y; Reiser G
    J Neurochem; 2005 Aug; 94(4):1054-62. PubMed ID: 16092946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain.
    Zhang MR; Ogawa M; Maeda J; Ito T; Noguchi J; Kumata K; Okauchi T; Suhara T; Suzuki K
    J Med Chem; 2006 May; 49(9):2735-42. PubMed ID: 16640334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of peripheral vs central benzodiazepine receptor selectivity in a new class of peripheral benzodiazepine receptor ligands related to alpidem.
    Anzini M; Cappelli A; Vomero S; Giorgi G; Langer T; Bruni G; Romeo MR; Basile AS
    J Med Chem; 1996 Oct; 39(21):4275-84. PubMed ID: 8863805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased densities of binding sites for the "peripheral-type" benzodiazepine receptor ligand [3H]PK11195 in vulnerable regions of the rat brain in thiamine deficiency encephalopathy.
    Leong DK; Le O; Oliva L; Butterworth RF
    J Cereb Blood Flow Metab; 1994 Jan; 14(1):100-5. PubMed ID: 8263044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of a glioma using peripheral benzodiazepine receptor ligands.
    Starosta-Rubinstein S; Ciliax BJ; Penney JB; McKeever P; Young AB
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):891-5. PubMed ID: 3027710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man.
    Black KL; Ikezaki K; Santori E; Becker DP; Vinters HV
    Cancer; 1990 Jan; 65(1):93-7. PubMed ID: 2152852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands.
    Okubo T; Yoshikawa R; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2004 Jan; 12(2):423-38. PubMed ID: 14723961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the mammalian TSPO/PBR protein.
    Jaremko M; Jaremko Ł; Jaipuria G; Becker S; Zweckstetter M
    Biochem Soc Trans; 2015 Aug; 43(4):566-71. PubMed ID: 26551694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.